0001878646-22-000032.txt : 20220715 0001878646-22-000032.hdr.sgml : 20220715 20220715114826 ACCESSION NUMBER: 0001878646-22-000032 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220715 DATE AS OF CHANGE: 20220715 EFFECTIVENESS DATE: 20220715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CorriXR Therapeutics, Inc. CENTRAL INDEX KEY: 0001938281 IRS NUMBER: 881652983 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-452572 FILM NUMBER: 221084858 BUSINESS ADDRESS: STREET 1: 501 WEST 14TH STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302-623-5305 MAIL ADDRESS: STREET 1: 501 WEST 14TH STREET CITY: WILMINGTON STATE: DE ZIP: 19801 D 1 primary_doc.xml X0708 D LIVE 0001938281 CorriXR Therapeutics, Inc. 501 WEST 14TH STREET WILMINGTON DE DELAWARE 19801 302-623-5305 DELAWARE None None Corporation true 2022 Eric Kmiec 501 West 14th Street Wilmington DE DELAWARE 19801 Executive Officer Director Jeffrey Carper 501 West 14th Street Wilmington DE DELAWARE 19081 Director Janice Nevin 501 West 14th Street Wilmington DE DELAWARE 19801 Director Biotechnology Decline to Disclose 06b false 2022-06-30 false true false 0 8028610 2499998 5528612 false 1 0 0 0 false CorriXR Therapeutics, Inc. /s/Eric B. Kmiec Eric B. Kmiec Interim Chief Executive Officer 2022-07-15